GROUP ONE TRADING, L.P. - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 32 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$77,000
+102.6%
9,242
+66.4%
0.00%
Q4 2021$38,000
-73.4%
5,553
-79.5%
0.00%
Q3 2021$143,000
-76.4%
27,056
-74.3%
0.00%
-100.0%
Q2 2021$605,000
-22.1%
105,248
-47.8%
0.00%
-83.3%
Q1 2020$777,000
+26.3%
201,698
+23.1%
0.01%
+50.0%
Q4 2019$615,000
-38.0%
163,903
-12.3%
0.00%
-50.0%
Q3 2019$992,000
+593.7%
186,798
+402.0%
0.01%
+700.0%
Q2 2019$143,000
+346.9%
37,212
+122.0%
0.00%
Q4 2018$32,000
-40.7%
16,764
+17.2%
0.00%
Q3 2018$54,000
+42.1%
14,306
+17.0%
0.00%
Q2 2018$38,000
+660.0%
12,224
+515.8%
0.00%
Q1 2018$5,000
-16.7%
1,985
+26.1%
0.00%
Q4 2017$6,0000.0%1,574
-38.3%
0.00%
Q3 2017$6,000
+50.0%
2,553
+82.6%
0.00%
Q3 2015$4,000
-93.9%
1,398
-94.7%
0.00%
-100.0%
Q2 2014$66,000
+127.6%
26,248
+107.1%
0.00%
Q1 2014$29,000
+16.0%
12,676
-1.7%
0.00%
Q4 2013$25,00012,9000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$1,902,0005.68%
GABLES CAPITAL MANAGEMENT INC. 433,814$5,566,0004.46%
Quantedge Capital Pte Ltd 503,700$6,462,0001.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,896,000$62,816,0001.25%
Lanham O'Dell & Company, Inc. 20,145$258,0000.92%
Capital Impact Advisors, LLC 59,301$907,0000.90%
SummerHaven Investment Management, LLC 98,840$1,268,0000.88%
Yorktown Management & Research Co Inc 50,000$642,0000.83%
GLOBEFLEX CAPITAL L P 304,293$3,904,0000.67%
AFFINITY INVESTMENT ADVISORS, LLC 90,864$1,166,0000.60%
View complete list of CATALYST PHARMACEUTICALS INC shareholders